Review of Diabetes Drug Safety Concerns (David Kendall, MD)


Review of diabetes drug safety concerns (David Kendall, MD) – David Kendall, MD from the International Diabetes Center in Minneapolis, MN discusses recent concerns on diabetes drug safety including TZDs, GLP-1 agonists and long-acting insulin analogs. Provided by the Institute for Diabetes, Obesity, and Cardiovascular Disease (iDOC), a free resource for continuing medical education and other tools for medical professionals focused on the treatment of these three related conditions. Visit for more information.


Minnesota news in brief at 7:58 pm CST

Filed under: mn

It focuses on upgrading Mayo's research and care facilities and on giving its mid-sized host city amenities that make it more attractive to physicians being recruited and to the patients who come from across the globe for treatment. Dr. John Noseworthy …
Read more on Palm Beach Post


Source: A-Rod could face PED suspension

Filed under: drug treatment centers mn

Documents dating to 2009 outline the drugs prescribed to Rodriguez and how much he paid, including $ 3,500 for one treatment. According to New Times, Bosch wrote in a personal notebook of Rodriguez: "1.5/1.5 HGH (sports perf.) creams test., glut., MIC, …
Read more on KARE


Obama's blueprint

Filed under: drug treatment centers mn

Officials from Wisconsin, Minnesota, Colorado, West Virginia and Rhode Island have worked with Jonathan Gruber, an MIT economics professor who helped craft both the state and federal laws, to set up their exchanges. What are they getting in return …
Read more on The Register-Guard


Tags: ,

Leave a Reply

Your email address will not be published. Required fields are marked *